Under the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of ...

COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its ...

The decision comes amid a leadership shakeup at the Danish drugmaker. Current chair Helge Lund and six other independent ...

As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra in India.

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with ...

Emcure becomes first Indian company to commercialise semaglutide 2.4 mg, the second brand of Wegovy®, in India.

Stocks climbed and Treasuries dropped as hopes for a deal to end the longest US government shutdown lifted sentiment after a ...

Stocks climbed and Treasuries dropped as hopes for a deal to end the longest US government shutdown lifted sentiment after a ...

Pfizer has clinched a US$10 billion deal to acquire obesity drug developer Metsera, ending a heated bidding war with Danish ...

Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.

The Danish pharmaceutical giant is confronting one of its most severe crises in recent memory. A perfect storm of unfavorable ...